Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Completed
National Cancer Institute (NCI)
Phase 2
1988-04-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone
marrow or peripheral stem cell transplantation may allow the doctor to give higher doses of
chemotherapy to kill more cancer cells.
PURPOSE: This phase II trial is studying giving high-dose chemotherapy followed by bone
marrow or peripheral stem cell transplantation to see how well it works in treating patients
with refractory Hodgkin's disease or non-Hodgkin's lymphoma.
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Completed
Albert Einstein College of Medicine of Yeshiva University
Phase 2
1988-04-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone
marrow or peripheral stem cell transplantation may allow the doctor to give higher doses of
chemotherapy to kill more cancer cells.
PURPOSE: This phase II trial is studying giving high-dose chemotherapy followed by bone
marrow or peripheral stem cell transplantation to see how well it works in treating patients
with refractory Hodgkin's disease or non-Hodgkin's lymphoma.
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Completed
Montefiore Medical Center
Phase 2
1988-04-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone
marrow or peripheral stem cell transplantation may allow the doctor to give higher doses of
chemotherapy to kill more cancer cells.
PURPOSE: This phase II trial is studying giving high-dose chemotherapy followed by bone
marrow or peripheral stem cell transplantation to see how well it works in treating patients
with refractory Hodgkin's disease or non-Hodgkin's lymphoma.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
